CRP and lymphopenia: Several reports of non-MHD patients with COVID-19 have described elevated levels of neutrophils and CRP with lymphopenia [13, 23, 26], but very few reports have considered the cost-effective markers NLR, PLR, MLR, and LCR to aid complication predictions and response to the therapeutic measures performed.